Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2018 2
2019 3
2020 1
2021 4
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Polypharmacology in the Treatment of Chagas Disease.
Aguilera E, Alvarez G, Cerecetto H, González M. Aguilera E, et al. Curr Med Chem. 2019;26(23):4476-4489. doi: 10.2174/0929867325666180410101728. Curr Med Chem. 2019. PMID: 29637852 Review.
Antiprotozoal Compounds from Urolepis hecatantha (Asteraceae).
Elso OG, Clavin M, Hernandez N, Sgarlata T, Bach H, Catalan CAN, Aguilera E, Alvarez G, Sülsen VP. Elso OG, et al. Among authors: aguilera e. Evid Based Complement Alternat Med. 2021 Feb 11;2021:6622894. doi: 10.1155/2021/6622894. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33628303 Free PMC article.
Preclinical Studies in Anti-Trypanosomatidae Drug Development.
Perdomo C, Aguilera E, Corvo I, Faral-Tello P, Serna E, Robello C, Wilkinson SR, Yaluff G, Alvarez G. Perdomo C, et al. Among authors: aguilera e. Pharmaceuticals (Basel). 2021 Jul 5;14(7):644. doi: 10.3390/ph14070644. Pharmaceuticals (Basel). 2021. PMID: 34358070 Free PMC article.
Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease.
Aguilera E, Sánchez C, Cruces ME, Dávila B, Minini L, Mosquillo F, Pérez-Díaz L, Serna E, Torres S, Schini A, Sanabria L, Vera de Bilbao NI, Yaluff G, Zolessi FR, Ceilas LF, Cerecetto H, Alvarez G. Aguilera E, et al. Pharmaceuticals (Basel). 2022 Dec 23;16(1):20. doi: 10.3390/ph16010020. Pharmaceuticals (Basel). 2022. PMID: 36678516 Free PMC article.
A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.
Aguilera E, Perdomo C, Espindola A, Corvo I, Faral-Tello P, Robello C, Serna E, Benítez F, Riveros R, Torres S, Vera de Bilbao NI, Yaluff G, Alvarez G. Aguilera E, et al. Molecules. 2019 Oct 22;24(20):3800. doi: 10.3390/molecules24203800. Molecules. 2019. PMID: 31652542 Free PMC article.
Synthesis and Antitrypanosomal and Mechanistic Studies of a Series of 2-Arylquinazolin-4-hydrazines: A Hydrazine Moiety as a Selective, Safe, and Specific Pharmacophore to Design Antitrypanosomal Agents Targeting NO Release.
Romero AH, Aguilera E, Gotopo L, Charris J, Rodríguez N, Oviedo H, Dávila B, Cabrera G, Cerecetto H. Romero AH, et al. Among authors: aguilera e. ACS Omega. 2022 Dec 6;7(50):47225-47238. doi: 10.1021/acsomega.2c06455. eCollection 2022 Dec 20. ACS Omega. 2022. PMID: 36570252 Free PMC article.
15 results